Puriblood Medical Co., Ltd. (TPEX:6847)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
74.10
+0.60 (0.82%)
Feb 11, 2026, 2:56 PM CST

Puriblood Medical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,0541,4301,6011,9282,305-
Market Cap Growth
-26.63%-10.67%-16.97%-16.36%--
Enterprise Value
1,0281,3821,5621,8672,169-
Last Close Price
74.10100.50112.50135.50162.00-
PE Ratio
---116.62--
PS Ratio
8.9912.9212.7814.0342.23-
PB Ratio
6.458.158.848.2710.65-
P/TBV Ratio
6.818.639.498.8611.11-
P/FCF Ratio
--78.48---
P/OCF Ratio
--60.08---
EV/Sales Ratio
8.7612.4912.4713.5939.73-
EV/EBITDA Ratio
-348.23-138.76--
EV/EBIT Ratio
---257.98--
EV/FCF Ratio
-41.44-76.56---
Debt / Equity Ratio
0.340.300.280.240.140.24
Debt / EBITDA Ratio
6.769.55-3.80-22.17
Debt / FCF Ratio
--2.53---
Net Debt / Equity Ratio
-0.16-0.20-0.36-0.18-0.47-0.46
Net Debt / EBITDA Ratio
-3.91-8.761.50-3.193.32-970.22
Net Debt / FCF Ratio
1.051.10-3.231.302.173.39
Asset Turnover
0.470.420.430.470.240.27
Inventory Turnover
1.371.754.313.274.313.26
Quick Ratio
1.772.803.163.416.417.04
Current Ratio
2.813.813.885.817.997.42
Return on Equity (ROE)
-4.50%-3.01%-24.91%7.36%-21.09%-3.25%
Return on Assets (ROA)
0.04%-0.65%-10.75%1.54%-9.58%-1.46%
Return on Invested Capital (ROIC)
0.12%-2.14%-33.00%4.63%-36.66%-4.93%
Return on Capital Employed (ROCE)
0.10%-1.20%-22.30%2.50%-14.50%-1.80%
Earnings Yield
-0.71%-0.38%-3.22%0.86%-1.65%-
FCF Yield
-2.35%-2.22%1.27%-1.71%-2.03%-
Buyback Yield / Dilution
----22.10%-35.52%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.